Research and Development: Page 5

Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer

By LabPulse.com staff writers

Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.

September 18, 2023

African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics

By LabPulse.com staff writers

A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.

September 18, 2023

Moderna’s mRNA flu shot yields promising results in phase III trial

By LabPulse.com staff writers

Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.

September 15, 2023

U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases

By Matt Limb

U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.

September 14, 2023

NIH awarding $50.3M to establish multiomics consortium

By LabPulse.com staff writers

The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.

September 14, 2023

Navigate BioPharma, Becton Dickinson collaborate on CDx solutions

By LabPulse.com staff writers

Navigate BioPharma and Becton Dickinson have formed a strategic collaboration to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions.

September 11, 2023

Cell-penetrating peptide selectively kills melanoma cells in study

By Matt Limb

Scientists have voiced fresh hopes for metastatic skin cancer therapy after identifying a way to kill melanoma cells efficiently and selectively while sparing normal cells, according to a recent study.

September 8, 2023

Roche’s Alecensa improves survival in postsurgery lung cancer patients in late-phase trial

By Nick Paul Taylor

Roche’s Alecensa has improved disease-free survival in non-small cell lung cancer patients, positioning the Swiss drugmaker to apply to expand the product label.

September 8, 2023

Actome outlines sequencing expansion plans as EU funding kicks in

By Nick Paul Taylor

Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”

September 7, 2023

Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development

By LabPulse.com staff writers

Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.

September 5, 2023

RNA exporters enable nondestructive cell monitoring, delivery of therapeutics

By Nick Paul Taylor

RNA exporters could enable the nondestructive monitoring of cells over time and the targeted delivery of mRNA therapeutics, according to a paper published recently in Cell.

September 5, 2023

Oral therapy combination yields promising results in multiple myeloma study

By LabPulse.com staff writers

A new agent that can be taken once daily in pill form showed promising results in a clinical trial when used in combination with a steroid in patients with multiple myeloma who had relapsed and stopped responding to currently available therapies.

September 1, 2023

Previous Page

Page 5 of 39

Next Page